Showing 4901-4910 of 5910 results for "".
- Prediabetes Linked to Macular Thinninghttps://modernod.com/news/prediabetes-linked-to-macular-thinning/2478592/Prediabetes is associated with significant thinning of the macula and with decreases in retinal-artery diameters, according to a population-based study. Various retinal changes have been reported in individuals with impaired fasting glucose or hyperglycemia, but it remains unclear whether
- Bausch Health Initiates Second Phase 3 Study for Investigational Treatment for Dry Eye Disease Associated With MGDhttps://modernod.com/news/bausch-health-initiates-second-phase-3-study-for-nov03-investigational-treatment-for-dry-eye-disease-associated-with-meibomian-gland-dysfunction/2478590/Bausch + Lomb announced the initiation of the second of two phase 3 studies evaluating the investigational treatment NOV03 (perfluorohexyloctane) as a first-in-class investigational drug with a novel mechanism of action to treat the signs and symptoms of dry eye disease (DED) associated with meib
- Oculus Names New Medical Directorhttps://modernod.com/news/oculus-names-new-medical-director/2478589/Oculus has announced that William Tullo, OD, FAAO, joined the company as a Medical Director on November 2nd, 2020. In this newly developed role, Dr. Tullo will provide clinical guidance and educate medical eye profess
- NovaBay Pharmaceuticals Expands Avenova’s Geographic Reach to Australia with New Exclusive Distribution Agreementhttps://modernod.com/news/novabay-pharmaceuticals-expands-avenovas-geographic-reach-to-australia-with-new-exclusive-distribution-agreement/2478586/NovaBay Pharmaceuticals announced the signing of an agreement with Paragon Care Group Australia Pty for the exclusive distribution of Avenova in Australia. Paragon Care Group will begin distributing Avenova directly to consumers under its Designs For Vision brand beginning in early 2021. “
- Topcon Announces the European Launch of Chronoshttps://modernod.com/news/topcon-announces-the-european-launch-of-chronos/2478579/Topcon Healthcare announced the European launch of the Chronos Automated Binocular Refraction System with SightPilot guided refraction software. Topcon Chronos is a complete digital refraction solution that combines autorefraction, keratometry, and subjective refraction in a single device.
- Wayne State Researchers Identify Cornea as a Potential Carrier of COVID-19https://modernod.com/news/wayne-state-researchers-identify-cornea-as-a-potential-carrier-of-covid-19/2478580/Scientists in the Department of Ophthalmology, Visual and Anatomical Sciences at the Wayne State University School of Medicine in Detroit have revealed that COVID-19 patients might harbor the virus in their eyes, demanding screening of ocular tissues before transplant surgeries during the pandemi
- Data Confirm Immune Response From AstraZeneca’s COVID-19 Vaccine in Elderlyhttps://modernod.com/news/data-confirm-immune-response-from-astrazenecas-covid-19-vaccine-in-elderly/2478582/Study results published in The Lancet suggest that the chimpanzee adenovirus-vectored COVID-19 vaccine being developed by AstraZeneca and the University of Oxford is able to produce a strong immune response in older adults, whilst being better tolerated in this age group than compared wi
- CEO says Pfizer “Very Close” to Filing COVID-19 Vaccine for US Emergency Usehttps://modernod.com/news/ceo-says-pfizer-very-close-to-filing-covid-19-vaccine-for-us-emergency-use/2478573/Pfizer CEO Albert Bourla suggested Tuesday that an FDA emergency-use authorization (EUA) request for the coronavirus vaccine it is co-developing with BioNTech is imminent. “We are very close to submitting for an [EUA],” Bourla reportedly said at a STAT News summit, but he would not sp
- Pfizer, BioNTech’s COVID-19 Vaccine Shows 95% Efficacy Rate at Final Analysishttps://modernod.com/news/pfizer-biontechs-covid-19-vaccine-shows-95-efficacy-rate-at-final-analysis/2478571/Pfizer and BioNTech announced Wednesday that their mRNA-based COVID-19 vaccine candidate BNT162b2 demonstrated an efficacy rate of 95% at the final efficacy analysis of a phase 3 study. The companies noted the primary objective analysis is based on 170 cases of COVID-19, of which 162 cases were o
- Amazon Unveils Pharmacy Offering, Hitting Shares of Drug Retailershttps://modernod.com/news/amazon-unveils-pharmacy-offering-hitting-shares-of-drug-retailers/2478569/Amazon.com announced Tuesday the launch of Amazon Pharmacy, allowing customers in the US to complete an entire pharmacy transaction on their desktop or mobile device through the Amazon app. The move sent shares in other drug retailers down, with Walgreens Boots falling over 11%, CVS Health slippi